Cited 0 times in
237 (PB117) - A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, KH | - |
dc.contributor.author | Lee, HJ | - |
dc.contributor.author | Lee, SJ | - |
dc.contributor.author | Kim, M | - |
dc.contributor.author | Ahn, MS | - |
dc.contributor.author | Choi, MY | - |
dc.contributor.author | Lee, NR | - |
dc.contributor.author | Jung, M | - |
dc.contributor.author | Shin, SJ | - |
dc.date.accessioned | 2023-04-20T04:36:05Z | - |
dc.date.available | 2023-04-20T04:36:05Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 0959-8049 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/25254 | - |
dc.language.iso | en | - |
dc.title | 237 (PB117) - A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ahn, MS | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1016/S0959-8049(22)01025-5 | - |
dc.citation.title | European journal of cancer (Oxford, England : 1990) | - |
dc.citation.volume | 174 | - |
dc.citation.number | S1 | - |
dc.citation.date | 2022 | - |
dc.citation.startPage | S85 | - |
dc.citation.endPage | S86 | - |
dc.identifier.bibliographicCitation | European journal of cancer (Oxford, England : 1990), 174(S1). : S85-S86, 2022 | - |
dc.embargo.liftdate | 9999-12-31 | - |
dc.embargo.terms | 9999-12-31 | - |
dc.identifier.eissn | 1879-0852 | - |
dc.relation.journalid | J009598049 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.